These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 10993232)

  • 1. The synthesis and human FP receptor binding affinity of 13,14-dihydro prostaglandin F1alpha sulfonamides: potential treatments for osteoporosis.
    Wang Y; Soper DL; Dirr MJ; deLong MA; De B; Wos JA
    Chem Pharm Bull (Tokyo); 2000 Sep; 48(9):1332-7. PubMed ID: 10993232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological evaluation of prostaglandin-F alkylphosphinic acid derivatives as bone anabolic agents for the treatment of osteoporosis.
    Soper DL; Milbank JB; Mieling GE; Dirr MJ; Kende AS; Cooper R; Jee WS; Yao W; Chen JL; Bodman M; Lundy MW; De B; Stella ME; Ebetino FH; Wang Y; deLong MA; Wos JA
    J Med Chem; 2001 Nov; 44(24):4157-69. PubMed ID: 11708917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and synthesis of 13,14-dihydro prostaglandin F(1alpha) analogues as potent and selective ligands for the human FP receptor.
    Wang Y; Wos JA; Dirr MJ; Soper DL; deLong MA; Mieling GE; De B; Amburgey JS; Suchanek EG; Taylor CJ
    J Med Chem; 2000 Mar; 43(5):945-52. PubMed ID: 10715159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthetic modification of prostaglandin f(2alpha) indicates different structural determinants for binding to the prostaglandin F receptor versus the prostaglandin transporter.
    Schuster VL; Itoh S; Andrews SW; Burk RM; Chen J; Kedzie KM; Gil DW; Woodward DF
    Mol Pharmacol; 2000 Dec; 58(6):1511-6. PubMed ID: 11093791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural requirements for prostaglandin analog interaction with the ovine corpus luteum prostaglandin F2 alpha receptor. Implications for development of a photoaffinity probe.
    Balapure AK; Rexroad CE; Kawada K; Watt DS; Fitz TA
    Biochem Pharmacol; 1989 Jul; 38(14):2375-81. PubMed ID: 2751699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-time intracellular Ca2+ mobilization by travoprost acid, bimatoprost, unoprostone, and other analogs via endogenous mouse, rat, and cloned human FP prostaglandin receptors.
    Kelly CR; Williams GW; Sharif NA
    J Pharmacol Exp Ther; 2003 Jan; 304(1):238-45. PubMed ID: 12490597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bimatoprost and its free acid are prostaglandin FP receptor agonists.
    Sharif NA; Williams GW; Kelly CR
    Eur J Pharmacol; 2001 Dec; 432(2-3):211-3. PubMed ID: 11740958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ocular hypotensive FP prostaglandin (PG) analogs: PG receptor subtype binding affinities and selectivities, and agonist potencies at FP and other PG receptors in cultured cells.
    Sharif NA; Kelly CR; Crider JY; Williams GW; Xu SX
    J Ocul Pharmacol Ther; 2003 Dec; 19(6):501-15. PubMed ID: 14733708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular pharmacology of the DP/EP2 class prostaglandin AL-6598 and quantitative autoradiographic visualization of DP and EP2 receptor sites in human eyes.
    Sharif NA; Williams GW; Crider JY; Xu SX; Davis TL
    J Ocul Pharmacol Ther; 2004 Dec; 20(6):489-508. PubMed ID: 15684809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacology of [3H]prostaglandin E1/[3H]prostaglandin E2 and [3H]prostaglandin F2alpha binding to EP3 and FP prostaglandin receptor binding sites in bovine corpus luteum: characterization and correlation with functional data.
    Sharif NA; Xu SX; Williams GW; Crider JY; Griffin BW; Davis TL
    J Pharmacol Exp Ther; 1998 Aug; 286(2):1094-102. PubMed ID: 9694973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostaglandin F(2alpha) receptor-dependent regulation of prostaglandin transport.
    Vezza R; Rokach J; FitzGerald GA
    Mol Pharmacol; 2001 Jun; 59(6):1506-13. PubMed ID: 11353812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and in vitro evaluation of human FP-receptor selective prostaglandin analogues.
    deLong MA; Amburgey J; Taylor C; Wos JA; Soper DL; Wang Y; Hicks R
    Bioorg Med Chem Lett; 2000 Jul; 10(14):1519-22. PubMed ID: 10915040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Agonist activity of bimatoprost, travoprost, latanoprost, unoprostone isopropyl ester and other prostaglandin analogs at the cloned human ciliary body FP prostaglandin receptor.
    Sharif NA; Kelly CR; Crider JY
    J Ocul Pharmacol Ther; 2002 Aug; 18(4):313-24. PubMed ID: 12222762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 11β-Prostaglandin F2α, a bioactive metabolite catalyzed by AKR1C3, stimulates prostaglandin F receptor and induces slug expression in breast cancer.
    Yoda T; Kikuchi K; Miki Y; Onodera Y; Hata S; Takagi K; Nakamura Y; Hirakawa H; Ishida T; Suzuki T; Ohuchi N; Sasano H; McNamara KM
    Mol Cell Endocrinol; 2015 Sep; 413():236-47. PubMed ID: 26170067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AL-8810: a novel prostaglandin F2 alpha analog with selective antagonist effects at the prostaglandin F2 alpha (FP) receptor.
    Griffin BW; Klimko P; Crider JY; Sharif NA
    J Pharmacol Exp Ther; 1999 Sep; 290(3):1278-84. PubMed ID: 10454504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Replacement of the carboxylic acid group of prostaglandin f(2alpha) with a hydroxyl or methoxy substituent provides biologically unique compounds.
    Woodward DF; Krauss AH; Chen J; Gil DW; Kedzie KM; Protzman CE; Shi L; Chen R; Krauss HA; Bogardus A; Dinh HT; Wheeler LA; Andrews SW; Burk RM; Gac T; Roof MB; Garst ME; Kaplan LJ; Sachs G; Pierce KL; Regan JW; Ross RA; Chan MF
    Br J Pharmacol; 2000 Aug; 130(8):1933-43. PubMed ID: 10952685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on receptor binding and signal transduction pathways of unoprostone isopropyl.
    Bhattacherjee P; Paterson CA; Percicot C
    J Ocul Pharmacol Ther; 2001 Oct; 17(5):433-41. PubMed ID: 11765148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stable 9 beta- or 11 alpha-halogen-15-cyclohexyl-prostaglandins with high affinity to the PGD2-receptor.
    Thierauch KH; Stürzebecher CS; Schillinger E; Rehwinkel H; Radüchel B; Skuballa W; Vorbrüggen H
    Adv Prostaglandin Thromboxane Leukot Res; 1989; 19():655-8. PubMed ID: 2526554
    [No Abstract]   [Full Text] [Related]  

  • 19. IOP-Lowering Effect of ONO-9054, A Novel Dual Agonist of Prostanoid EP3 and FP Receptors, in Monkeys.
    Yamane S; Karakawa T; Nakayama S; Nagai K; Moriyuki K; Neki S; Suto F; Kambe T; Hirota Y; Kawabata K
    Invest Ophthalmol Vis Sci; 2015 Apr; 56(4):2547-52. PubMed ID: 25788650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human trabecular meshwork cell responses induced by bimatoprost, travoprost, unoprostone, and other FP prostaglandin receptor agonist analogues.
    Sharif NA; Kelly CR; Crider JY
    Invest Ophthalmol Vis Sci; 2003 Feb; 44(2):715-21. PubMed ID: 12556403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.